VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...
MaaT Pharma Announces Positive Second Safety Interim Analysis from DSMB for Phase 2b PHOEBUS Trial Evaluating MaaT033 for ...
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...
ScreenPoint Medical today announced that its Transpara ® breast imaging AI solution has been selected as the technology of ...
GPT-4 variants excel at checking AI trial consistency with CONSORT-AI. Keep reading to see how LLMs are shaping research ...
A total of 295 eligible patients were enrolled with a median follow-up of 5.0 years. The arms were well balanced, with a ...
In addition to the cognitive findings, the Company will present two additional posters at the 38th ECNP Congress: an encore ...
Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...
International Survey of Psychosocial Care for Cancer Survivors in Low-/Middle- and High-Income Countries: Current Practices, Barriers, and Facilitators to Care Patients receiving capsaicin had a ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...